Ippei Fukada Selected Research

Pulmonary Hypertension

1/2016	Imatinib could be a new strategy for pulmonary hypertension caused by pulmonary tumor thrombotic microangiopathy in metastatic breast cancer.
4/2015	Imatinib alleviated pulmonary hypertension caused by pulmonary tumor thrombotic microangiopathy in a patient with metastatic breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ippei Fukada Research Topics

Disease

20	Breast Neoplasms (Breast Cancer) 05/2022 - 11/2014
10	Neoplasms (Cancer) 05/2022 - 01/2013
5	Neoplasm Metastasis (Metastasis) 10/2018 - 10/2009
2	Pulmonary Hypertension 01/2016 - 04/2015
2	Thrombotic Microangiopathies 01/2016 - 04/2015
1	Neutropenia 10/2017
1	Macular Edema 05/2017
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2017
1	Hypoxia (Hypoxemia) 01/2016
1	Dyspnea (Shortness of Breath) 01/2016
1	Fatty Liver 01/2016
1	Liver Diseases (Liver Disease) 01/2016
1	Disease Progression 12/2015
1	Adenocarcinoma 01/2015
1	Scirrhous Adenocarcinoma (Scirrhous Carcinoma) 01/2015
1	Clear Cell Sarcoma 01/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2009

Drug/Important Bio-Agent (IBA)

5	Trastuzumab (Herceptin)FDA Link 01/2022 - 12/2015
5	eribulin FDA Link 12/2021 - 01/2016
5	taxaneIBA 12/2021 - 01/2015
4	ErbB Receptors (EGF Receptor)IBA 05/2022 - 11/2014
4	Hormones (Hormone)IBA 01/2022 - 07/2016
4	AnthracyclinesIBA 12/2021 - 01/2015
4	Capecitabine (Xeloda)FDA Link 01/2016 - 11/2014
3	Phenobarbital (Luminal)FDA Link 01/2018 - 01/2016
2	Circulating Tumor DNAIBA 05/2022 - 04/2020
2	Fulvestrant (Faslodex)FDA Link 01/2022 - 07/2016
2	human ERBB2 proteinIBA 01/2022 - 10/2018
2	Taxoids (Taxanes)IBA 12/2021 - 07/2016
2	pertuzumabIBA 10/2018 - 10/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2017 - 01/2017
2	thiamine triphosphorate (TTP)IBA 07/2016 - 07/2016
2	Imatinib Mesylate (Gleevec)FDA Link 01/2016 - 04/2015
2	Lapatinib (GW572016)FDA Link 12/2015 - 11/2014
1	Cyclin-Dependent Kinase 4IBA 05/2022
1	AntigensIBA 05/2022
1	Tumor Biomarkers (Tumor Markers)IBA 05/2022
1	Carcinoembryonic AntigenIBA 05/2022
1	Estrogen ReceptorsIBA 05/2022
1	Cell-Free Nucleic AcidsIBA 04/2020
1	130-nm albumin-bound paclitaxelIBA 10/2018
1	Pharmaceutical PreparationsIBA 05/2017
1	Retinaldehyde (Retinal)IBA 05/2017
1	Bevacizumab (Avastin)FDA Link 05/2017
1	Aromatase InhibitorsIBA 07/2016
1	Therapeutic UsesIBA 07/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Tyrosine Kinase InhibitorsIBA 01/2016
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2016
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2015
1	Methotrexate (Mexate)FDA LinkGeneric 01/2015
1	4-azidobenzylcarazolol (pABC)IBA 01/2015
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2015
1	MART-1 AntigenIBA 01/2013
1	Melanins (Melanin)IBA 01/2013
1	Gemcitabine FDA Link 10/2009

Therapy/Procedure

8	Therapeutics 05/2022 - 02/2015
7	Drug Therapy (Chemotherapy) 10/2018 - 10/2009
4	Neoadjuvant Therapy 12/2021 - 01/2016
2	Segmental Mastectomy (Lumpectomy) 05/2017 - 01/2015
1	Drug Tapering 10/2017
1	Lymph Node Excision (Lymph Node Dissection) 05/2017
1	Time-to-Treatment 01/2017
1	Combination Drug Therapy (Combination Chemotherapy) 01/2015
1	Aftercare (After-Treatment) 01/2015